SMC acceptance offers new option for patients

Delayed‑release mercaptamine approved for routine use

Stablepharma’s thermostable td shot delivers strong phase 1 data

Regulator backs gene therapy for PKP2-ACM

Programme celebrates partnership excellence

Acalabrutinib combinations approved for CLL and MCL

First patient enrolled in Agni-01 expansion

Postmenopausal study highlights oral anabolic potential

Decision expands options for eligible patients

Study evaluates tri‑specific T cell engager LBL‑051